Forskning ved Københavns Universitet - Københavns Universitet

Forside

Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • Katerina Chatzidionysiou
  • Elisabeth Lie
  • Evgeny Nasonov
  • Galina Lukina
  • Hetland, Merete Lund
  • Ulrik Tarp
  • Cem Gabay
  • Piet L C M van Riel
  • Dan C Nordström
  • Juan Gomez-Reino
  • Karel Pavelka
  • Matija Tomsic
  • Tore K Kvien
  • Ronald F van Vollenhoven
To assess the 6-month effectiveness of the first rituximab (RTX) course in rheumatoid arthritis (RA) and to identify possible predictors of response.
OriginalsprogEngelsk
TidsskriftAnnals of the Rheumatic Diseases
Vol/bind70
Udgave nummer9
Sider (fra-til)1575-1580
Antal sider6
ISSN0003-4967
DOI
StatusUdgivet - 2011

ID: 40159623